Cost Analysis of Voriconazole Versus Liposomal Amphotericin B for Primary Therapy of Invasive Aspergillosis among High-Risk Hematologic Cancer Patients in Brazil
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.257
https://www.valueinhealthjournal.com/article/S1098-3015(15)02333-5/fulltext
Title :
Cost Analysis of Voriconazole Versus Liposomal Amphotericin B for Primary Therapy of Invasive Aspergillosis among High-Risk Hematologic Cancer Patients in Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02333-5&doi=10.1016/j.jval.2015.09.257
First page :
A820
Section Title :
Research Podium Presentations - Session 1
Open access? :
No
Section Order :
2477